BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: ACMG Board of Directors. Points to consider for informed consent for genome/exome sequencing. Genet Med 2013;15:748-9. [PMID: 23970068 DOI: 10.1038/gim.2013.94] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Erickson LA. Incidental findings in medical imaging and genetic testing: opportunities and challenges. Mayo Clin Proc 2014;89:715-7. [PMID: 24943690 DOI: 10.1016/j.mayocp.2014.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Henderson GE, Wolf SM, Kuczynski KJ, Joffe S, Sharp RR, Parsons DW, Knoppers BM, Yu JH, Appelbaum PS. The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J Law Med Ethics 2014;42:344-55. [PMID: 25264092 DOI: 10.1111/jlme.12151] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
3 Appelbaum PS, Parens E, Waldman CR, Klitzman R, Fyer A, Martinez J, Price WN 2nd, Chung WK. Models of consent to return of incidental findings in genomic research. Hastings Cent Rep 2014;44:22-32. [PMID: 24919982 DOI: 10.1002/hast.328] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
4 Kost RG, Poppel SM, Coller BS. Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators. J Clin Transl Sci 2017;1:115-20. [PMID: 28649453 DOI: 10.1017/cts.2016.21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Minari J, Brothers KB, Morrison M. Tensions in ethics and policy created by National Precision Medicine Programs. Hum Genomics 2018;12:22. [PMID: 29665847 DOI: 10.1186/s40246-018-0151-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
6 Gontika MP, Konialis C, Pangalos C, Papavasiliou A. Novel SCN1A and GABRA1 Gene Mutations With Diverse Phenotypic Features and the Question on the Existence of a Broader Spectrum of Dravet Syndrome. Child Neurol Open 2017;4:2329048X17706794. [PMID: 28540321 DOI: 10.1177/2329048X17706794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Diamonstein CJ. Factors complicating the informed consent process for whole exome sequencing in neonatal and pediatic intensive care units. J Genet Couns 2019;28:256-62. [DOI: 10.1002/jgc4.1097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 Tolusso LK, Collins K, Zhang X, Holle JR, Valencia CA, Myers MF. Pediatric Whole Exome Sequencing: an Assessment of Parents’ Perceived and Actual Understanding. J Genet Counsel 2017;26:792-805. [DOI: 10.1007/s10897-016-0052-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
9 Modell SM, Citrin T, Kardia SLR. Laying Anchor: Inserting Precision Health into a Public Health Genetics Policy Course. Healthcare (Basel) 2018;6:E93. [PMID: 30081448 DOI: 10.3390/healthcare6030093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Boothe M, Morris R, Robin N. Stickler Syndrome: A Review of Clinical Manifestations and the Genetics Evaluation. J Pers Med 2020;10:E105. [PMID: 32867104 DOI: 10.3390/jpm10030105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
11 Vears DF, Borry P, Savulescu J, Koplin JJ. Old Challenges or New Issues? Genetic Health Professionals' Experiences Obtaining Informed Consent in Diagnostic Genomic Sequencing. AJOB Empir Bioeth 2021;12:12-23. [PMID: 33017265 DOI: 10.1080/23294515.2020.1823906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 LeCompte LL, Young SJ. Revised Common Rule Changes to the Consent Process and Consent Form. Ochsner J 2020;20:62-75. [PMID: 32284685 DOI: 10.31486/toj.19.0055] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bush LW, Bartoshesky LE, David KL, Wilfond B, Williams JL, Holm IA; the ACMG SELI committee. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider—a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2018;20:692-4. [DOI: 10.1038/gim.2018.36] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
14 Bernhardt BA, Roche MI, Perry DL, Scollon SR, Tomlinson AN, Skinner D. Experiences with obtaining informed consent for genomic sequencing. Am J Med Genet A 2015;167A:2635-46. [PMID: 26198374 DOI: 10.1002/ajmg.a.37256] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 9.4] [Reference Citation Analysis]
15 Zaninetti C, Greinacher A. Diagnosis of Inherited Platelet Disorders on a Blood Smear. J Clin Med 2020;9:E539. [PMID: 32079152 DOI: 10.3390/jcm9020539] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
16 Knoppers BM, Zawati MH, Sénécal K. Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet 2015;16:553-9. [PMID: 26239711 DOI: 10.1038/nrg3960] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 14.0] [Reference Citation Analysis]
17 Yu JH, Appelbaum PS, Brothers KB, Joffe S, Kauffman TL, Koenig BA, Prince AE, Scollon S, Wolf SM, Bernhardt BA, Wilfond BS; Clinical Sequencing Exploratory Research (CSER) Consortium Informed Consent and Governance Working Group. Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium. Per Med 2019;16:325-33. [PMID: 31313633 DOI: 10.2217/pme-2018-0076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Kamalapathy P, Fonda Allen JS, Macri CJ, Lawrence AK, Regier DS, Rubio EI. Whole-exome sequencing for diagnosis of Peters-plus syndrome after prenatal diagnosis of recurrent low PAPP-A and multiple fetal anomalies in two consecutive pregnancies. J Neonatal Perinatal Med 2019. [PMID: 31081795 DOI: 10.3233/NPM-181854] [Reference Citation Analysis]
19 Remec ZI, Trebusak Podkrajsek K, Repic Lampret B, Kovac J, Groselj U, Tesovnik T, Battelino T, Debeljak M. Next-Generation Sequencing in Newborn Screening: A Review of Current State. Front Genet 2021;12:662254. [PMID: 34122514 DOI: 10.3389/fgene.2021.662254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Eno C, Bayrak-toydemir P, Bean L, Braxton A, Chao EC, El-khechen D, Esplin ED, Friedman B, Hagman KDF, Hambuch T, Hernandez A, Juusola J, Londre G, Machado J, Mao R, Mighion L, Rehm HL, Ward P, Deignan JL. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization. Genet Med 2019;21:861-6. [DOI: 10.1038/s41436-018-0265-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Greinacher A, Eekels JJM. Diagnosis of hereditary platelet disorders in the era of next-generation sequencing: "primum non nocere". J Thromb Haemost 2019;17:551-4. [PMID: 30614196 DOI: 10.1111/jth.14377] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
22 Mone F, Quinlan-Jones E, Kilby MD. Clinical utility of exome sequencing in the prenatal diagnosis of congenital anomalies: A Review. Eur J Obstet Gynecol Reprod Biol 2018;231:19-24. [PMID: 30317140 DOI: 10.1016/j.ejogrb.2018.10.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
23 Tomlinson AN, Skinner D, Perry DL, Scollon SR, Roche MI, Bernhardt BA. "Not Tied Up Neatly with a Bow": Professionals' Challenging Cases in Informed Consent for Genomic Sequencing. J Genet Couns 2016;25:62-72. [PMID: 25911622 DOI: 10.1007/s10897-015-9842-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
24 Jamuar SS, Tan EC. Clinical application of next-generation sequencing for Mendelian diseases. Hum Genomics 2015;9:10. [PMID: 26076878 DOI: 10.1186/s40246-015-0031-5] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
25 Krier JB, Kalia SS, Green RC. Genomic sequencing in clinical practice: applications, challenges, and opportunities. Dialogues Clin Neurosci 2016;18:299-312. [PMID: 27757064 [PMID: 27757064 DOI: 10.31887/dcns.2016.18.3/jkrier] [Cited by in Crossref: 33] [Article Influence: 6.6] [Reference Citation Analysis]
26 Srivastava S, Cohen JS, Vernon H, Barañano K, McClellan R, Jamal L, Naidu S, Fatemi A. Clinical whole exome sequencing in child neurology practice. Ann Neurol 2014;76:473-83. [PMID: 25131622 DOI: 10.1002/ana.24251] [Cited by in Crossref: 163] [Cited by in F6Publishing: 144] [Article Influence: 20.4] [Reference Citation Analysis]
27 Monaghan KG, Leach NT, Pekarek D, Prasad P, Rose NC; ACMG Professional Practice and Guidelines Committee. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2020;22:675-80. [PMID: 31911674 DOI: 10.1038/s41436-019-0731-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 20.5] [Reference Citation Analysis]
28 Smith LP. The Spectrum of Genetic Testing. Semin Oncol Nurs 2019;35:11-21. [PMID: 30660358 DOI: 10.1016/j.soncn.2018.12.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Zatz M, Passos-Bueno MR, Vainzof M. Neuromuscular disorders: genes, genetic counseling and therapeutic trials. Genet Mol Biol 2016;39:339-48. [PMID: 27575431 DOI: 10.1590/1678-4685-GMB-2016-0019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
30 Stefka J, El-Khechen D, Cain T, Blanco K, Feldmann B, Towne MC, Hagman KDF. Misattributed parentage identified through diagnostic exome sequencing: Frequency of detection and reporting practices. J Genet Couns 2021. [PMID: 34826357 DOI: 10.1002/jgc4.1530] [Reference Citation Analysis]
31 Peter M, McInnes-Dean H, Fisher J, Tapon D, Chitty LS, Hill M. What's out there for parents? A systematic review of online information about prenatal microarray and exome sequencing. Prenat Diagn 2021. [PMID: 34747021 DOI: 10.1002/pd.6066] [Reference Citation Analysis]
32 Arora S, Haverfield E, Richard G, Haga SB, Mills R. Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing. J Genet Counsel 2016;25:337-43. [DOI: 10.1007/s10897-015-9876-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
33 Boyd SD, Galli SJ, Schrijver I, Zehnder JL, Ashley EA, Merker JD. A Balanced Look at the Implications of Genomic (and Other "Omics") Testing for Disease Diagnosis and Clinical Care. Genes (Basel) 2014;5:748-66. [PMID: 25257203 DOI: 10.3390/genes5030748] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
34 Haga SB, Mills R. A review of consent practices and perspectives for pharmacogenetic testing. Pharmacogenomics 2016;17:1595-605. [PMID: 27533720 DOI: 10.2217/pgs-2016-0039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
35 Bowdin S, Gilbert A, Bedoukian E, Carew C, Adam MP, Belmont J, Bernhardt B, Biesecker L, Bjornsson HT, Blitzer M, D'Alessandro LC, Deardorff MA, Demmer L, Elliott A, Feldman GL, Glass IA, Herman G, Hindorff L, Hisama F, Hudgins L, Innes AM, Jackson L, Jarvik G, Kim R, Korf B, Ledbetter DH, Li M, Liston E, Marshall C, Medne L, Meyn MS, Monfared N, Morton C, Mulvihill JJ, Plon SE, Rehm H, Roberts A, Shuman C, Spinner NB, Stavropoulos DJ, Valverde K, Waggoner DJ, Wilkens A, Cohn RD, Krantz ID. Recommendations for the integration of genomics into clinical practice. Genet Med 2016;18:1075-84. [PMID: 27171546 DOI: 10.1038/gim.2016.17] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 14.7] [Reference Citation Analysis]
36 Kishnani PS, Goldstein J, Austin SL, Arn P, Bachrach B, Bali DS, Chung WK, El-Gharbawy A, Brown LM, Kahler S, Pendyal S, Ross KM, Tsilianidis L, Weinstein DA, Watson MS; ACMG Work Group on Diagnosis and Management of Glycogen Storage Diseases Type VI and IX. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2019;21:772-89. [PMID: 30659246 DOI: 10.1038/s41436-018-0364-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
37 Niemiec E, Borry P, Pinxten W, Howard HC. Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies. Hum Mutat 2016;37:1248-56. [PMID: 27647801 DOI: 10.1002/humu.23122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
38 Balcom JR, Kotzer KE, Waltman LA, Kemppainen JL, Thomas BC. The Genetic Counselor’s Role in Managing Ethical Dilemmas Arising in the Laboratory Setting. J Genet Counsel 2016;25:838-54. [DOI: 10.1007/s10897-016-9957-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Best S, Wou K, Vora N, Van der Veyver IB, Wapner R, Chitty LS. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn 2018;38:10-9. [PMID: 28654730 DOI: 10.1002/pd.5102] [Cited by in Crossref: 145] [Cited by in F6Publishing: 124] [Article Influence: 29.0] [Reference Citation Analysis]
40 Lalonde E, Rentas S, Lin F, Dulik MC, Skraban CM, Spinner NB. Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution. Front Pediatr 2020;8:373. [PMID: 32733828 DOI: 10.3389/fped.2020.00373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
41 Feinstein MA, Sharp RR, Sandness DJ, Feemster JC, Junna M, Kotagal S, Lipford MC, Tippmann-Peikert M, Boeve BF, Silber MH, St Louis EK. Physician and patient determinants of prognostic counseling in idiopathic REM sleep-behavior disorder. Sleep Med 2019;62:80-5. [PMID: 31581066 DOI: 10.1016/j.sleep.2019.03.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Bertier G, Sénécal K, Borry P, Vears DF. Unsolved challenges in pediatric whole-exome sequencing: A literature analysis. Crit Rev Clin Lab Sci 2017;54:134-42. [PMID: 28132577 DOI: 10.1080/10408363.2016.1275516] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
43 Dasgupta S. Medical Genetics Ethics Case Collection: Discussion Materials for Medical Students in the Genomic Era. MedEdPORTAL 2017;13:10562. [PMID: 30800764 DOI: 10.15766/mep_2374-8265.10562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
44 Cho YK, Lee SY, Kim SW. Novel ABCD1 Gene Mutation in a Korean Patient with X-Linked Adrenoleukodystrophy Presenting with Addison's Disease. Endocrinol Metab (Seoul) 2020;35:188-91. [PMID: 32207279 DOI: 10.3803/EnM.2020.35.1.188] [Reference Citation Analysis]
45 Scheuner MT, Russell MM, Chanfreau-Coffinier C, Peredo J, Yano EM, Hamilton AB, Lerner B, Provenzale D, Knight SJ, Voils CI. Stakeholders' views on the value of outcomes from clinical genetic and genomic interventions. Genet Med 2019;21:1371-80. [PMID: 30377384 DOI: 10.1038/s41436-018-0344-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Ménard T, Barros A, Ganter C. Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development. Ther Innov Regul Sci 2021;55:1066-74. [PMID: 34046876 DOI: 10.1007/s43441-021-00308-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Adam S, Friedman JM. Controversy and debate on clinical genomics sequencing-paper 2: clinical genome-wide sequencing: don't throw out the baby with the bathwater! J Clin Epidemiol 2017;92:7-10. [PMID: 28916491 DOI: 10.1016/j.jclinepi.2017.08.020] [Reference Citation Analysis]
48 Beale S, Sanderson D, Sanniti A, Dundar Y, Boland A. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children. Health Technol Assess 2015;19:1-90. [PMID: 26132578 DOI: 10.3310/hta19460] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
49 Lalani SR. Current Genetic Testing Tools in Neonatal Medicine. Pediatrics & Neonatology 2017;58:111-21. [DOI: 10.1016/j.pedneo.2016.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
50 O'Donnell-Luria AH, Miller DT. A Clinician's perspective on clinical exome sequencing. Hum Genet 2016;135:643-54. [PMID: 27126233 DOI: 10.1007/s00439-016-1662-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
51 Greinacher A, Eekels JJM. Simplifying the diagnosis of inherited platelet disorders? The new tools do not make it any easier. Blood 2019;133:2478-83. [PMID: 30858232 DOI: 10.1182/blood-2019-01-852350] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
52 Fowler SA, Saunders CJ, Hoffman MA. Variation among Consent Forms for Clinical Whole Exome Sequencing. J Genet Couns 2018;27:104-14. [PMID: 28689263 DOI: 10.1007/s10897-017-0127-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
53 Dong L, Wang W, Li A, Kansal R, Chen Y, Chen H, Li X. Clinical Next Generation Sequencing for Precision Medicine in Cancer. Curr Genomics 2015;16:253-63. [PMID: 27006629 DOI: 10.2174/1389202915666150511205313] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
54 Friedman E. Next generation sequencing for newborn screening: are we there yet? Genet Res (Camb) 2015;97:e17. [PMID: 26392239 DOI: 10.1017/S001667231500018X] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
55 Vos S, van Diest PJ, Ausems MG, van Dijk MR, de Leng WW, Bredenoord AL. Ethical considerations for modern molecular pathology: Ethical considerations for modern molecular pathology. J Pathol 2018;246:405-14. [DOI: 10.1002/path.5157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Yoshizawa G, Sasongko TH, Ho CH, Kato K. Social and Communicative Functions of Informed Consent Forms in East Asia and Beyond. Front Genet 2017;8:99. [PMID: 28775738 DOI: 10.3389/fgene.2017.00099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
57 Freed AS, Clowes Candadai SV, Sikes MC, Thies J, Byers HM, Dines JN, Ndugga-Kabuye MK, Smith MB, Fogus K, Mefford HC, Lam C, Adam MP, Sun A, McGuire JK, DiGeronimo R, Dipple KM, Deutsch GH, Billimoria ZC, Bennett JT. The Impact of Rapid Exome Sequencing on Medical Management of Critically Ill Children. J Pediatr 2020:S0022-3476(20)30721-6. [PMID: 32553838 DOI: 10.1016/j.jpeds.2020.06.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Knoppers BM, Senecal K, Borry P, Avard D. Whole-Genome Sequencing in Newborn Screening Programs. Science Translational Medicine 2014;6:229cm2-229cm2. [DOI: 10.1126/scitranslmed.3008494] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
59 Gore RH, Bridges JFP, Cohen JS, Biesecker BB. Challenges to informed consent for exome sequencing: A best-worst scaling experiment. J Genet Couns 2019;28:1189-97. [PMID: 31553105 DOI: 10.1002/jgc4.1171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Goswami RS, Harada S. An Overview of Molecular Genetic Diagnosis Techniques. Curr Protoc Hum Genet 2020;105:e97. [PMID: 32105409 DOI: 10.1002/cphg.97] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Niemiec E, Vears DF, Borry P, Howard HC. Readability of informed consent forms for whole-exome and whole-genome sequencing. J Community Genet 2018;9:143-51. [PMID: 28856579 DOI: 10.1007/s12687-017-0324-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
62 Chow-white PA, Macaulay M, Charters A, Chow P. From the bench to the bedside in the big data age: ethics and practices of consent and privacy for clinical genomics and personalized medicine. Ethics Inf Technol 2015;17:189-200. [DOI: 10.1007/s10676-015-9373-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 2.4] [Reference Citation Analysis]
63 Biesecker LG, Biesecker BB. An approach to pediatric exome and genome sequencing. Curr Opin Pediatr 2014;26:639-45. [PMID: 25304963 DOI: 10.1097/MOP.0000000000000150] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
64 Clowes Candadai SV, Sikes MC, Thies JM, Freed AS, Bennett JT. Rapid clinical exome sequencing in a pediatric ICU: Genetic counselor impacts and challenges. J Genet Couns 2019;28:283-91. [PMID: 30964580 DOI: 10.1002/jgc4.1116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
65 Shelton CA, Whitcomb DC. Evolving Roles for Physicians and Genetic Counselors in Managing Complex Genetic Disorders. Clin Transl Gastroenterol 2015;6:e124. [PMID: 26561988 DOI: 10.1038/ctg.2015.46] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
66 Lázaro-Muñoz G. The fiduciary relationship model for managing clinical genomic "incidental" findings. J Law Med Ethics 2014;42:576-89. [PMID: 25565622 DOI: 10.1111/jlme.12177] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
67 Hull LE, Vassy JL. Toward greater understanding of patient decision-making around genome sequencing. Per Med 2018;15:57-66. [PMID: 29714114 DOI: 10.2217/pme-2017-0037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
68 Ashton-Prolla P, Goldim JR, Vairo FP, da Silveira Matte U, Sequeiros J. Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil. J Community Genet 2015;6:275-83. [PMID: 26040235 DOI: 10.1007/s12687-015-0238-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
69 Kamalapathy P, Fonda Allen JS, Macri CJ, Lawrence AK, Regier DS, Rubio EI. Whole-exome sequencing for diagnosis of Peters-plus syndrome after prenatal diagnosis of recurrent low PAPP-A and multiple fetal anomalies in two consecutive pregnancies. J Neonatal Perinatal Med 2019;12:333-8. [PMID: 31476172 DOI: 10.3233/NPM-1854] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Schmidlen T, Sturm AC, Hovick S, Scheinfeldt L, Scott Roberts J, Morr L, McElroy J, Toland AE, Christman M, O'Daniel JM, Gordon ES, Bernhardt BA, Ormond KE, Sweet K. Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing. J Genet Couns 2018;27:1111-29. [PMID: 29460110 DOI: 10.1007/s10897-018-0230-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
71 Roche MI, Berg JS. Incidental Findings with Genomic Testing: Implications for Genetic Counseling Practice. Curr Genet Med Rep 2015;3:166-76. [PMID: 26566463 DOI: 10.1007/s40142-015-0075-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
72 Hallquist MLG, Tricou EP, Ormond KE, Savatt JM, Coughlin CR 2nd, Faucett WA, Hercher L, Levy HP, O'Daniel JM, Peay HL, Stosic M, Smith M, Uhlmann WR, Wand H, Wain KE, Buchanan AH. Application of a framework to guide genetic testing communication across clinical indications. Genome Med 2021;13:71. [PMID: 33926532 DOI: 10.1186/s13073-021-00887-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Hitchcock EC, Study C, Elliott AM. Shortened consent forms for genome-wide sequencing: Parent and provider perspectives. Mol Genet Genomic Med 2020;8:e1254. [PMID: 32383361 DOI: 10.1002/mgg3.1254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]